Cambridge Investment Research Advisors Inc. Has $2.86 Million Stock Holdings in DexCom, Inc. (NASDAQ:DXCM)

Cambridge Investment Research Advisors Inc. increased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 16.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 25,280 shares of the medical device company’s stock after acquiring an additional 3,656 shares during the […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Kevinr Sayer ,Matthew Vincent Dolan ,Raymond James ,James Investment Research Inc ,Exchange Commission ,Close Asset Management Ltd ,Wolfe Research ,Accurate Wealth Management ,Dexcom Company Profile ,Dexcom Inc ,Cambridge Investment Research Advisors Inc ,Nasdaq ,Atlas Capital Advisors ,Cambridge Investment Research Advisors ,Get Rating ,Investment Research Advisors ,Investment Research ,Asset Management Ltd ,Capital Advisors ,Wealth Management ,Vincent Dolan ,Dexcom Daily ,Dexcom ,Nasdaq Dxcm ,Dxcm ,Medical ,25213110 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,